Compare VCEL & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | FIGS |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 1996 | 2021 |
| Metric | VCEL | FIGS |
|---|---|---|
| Price | $39.44 | $14.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $60.57 | $18.63 |
| AVG Volume (30 Days) | 397.9K | ★ 2.4M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.00 | ★ 850.00 |
| EPS | N/A | ★ 0.18 |
| Revenue | $276,259,000.00 | ★ $419,591,000.00 |
| Revenue This Year | $21.71 | $20.59 |
| Revenue Next Year | $16.86 | $9.20 |
| P/E Ratio | ★ N/A | $78.89 |
| Revenue Growth | 16.45 | ★ 59.47 |
| 52 Week Low | $28.95 | $6.77 |
| 52 Week High | $49.32 | $17.48 |
| Indicator | VCEL | FIGS |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 54.26 |
| Support Level | $37.78 | $13.87 |
| Resistance Level | $41.12 | $15.94 |
| Average True Range (ATR) | 1.17 | 0.64 |
| MACD | 0.26 | 0.06 |
| Stochastic Oscillator | 69.65 | 84.27 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.